IncobotulinumtoxinA Pregnancy and Breastfeeding Warnings

IncobotulinumtoxinA is also known as: Xeomin

IncobotulinumtoxinA Pregnancy Warnings

IncobotulinumtoxinA has been assigned to pregnancy category C by the FDA. There are no adequate and well-controlled studies in pregnant women. IncobotulinumtoxinA was embryotoxic in rats and increased abortions in rabbits when given at doses higher than the maximum recommended human dose (MRHD) for cervical dystonia on a body weight basis. IncobotulinumtoxinA should only be given during pregnancy when the potential benefits outweigh the potential risks.

IncobotulinumtoxinA Breastfeeding Warnings

There are no data on the excretion of botulinum toxin type A into human milk. Because many drugs are excreted in human milk, caution should be exercised when incobotulinumtoxinA is administered to a nursing woman.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.